Neurological Complications at Stroke Patients With Diabetes Mellitus (SDM)
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT01172977|
Recruitment Status : Completed
First Posted : July 30, 2010
Last Update Posted : June 23, 2011
|Condition or disease|
|Stroke Diabetes Mellitus|
The immediate objective of the study is to find out if a correlation between blood sugar control in diabetics and the incidence of complications after a stroke exists.
The study has a high practical importance because any consequences in the treatment of diabetes mellitus can be implemented without affecting costs.
|Study Type :||Observational|
|Actual Enrollment :||100 participants|
|Observational Model:||Case Control|
|Official Title:||Neurological Complications at Stroke Patients With Diabetes Mellitus During the First Six Months After a Cerebral Ischemia|
|Study Start Date :||August 2010|
|Primary Completion Date :||March 2011|
|Study Completion Date :||March 2011|
HbA1c ≤ 7
Stroke patients with mild diabetes mellitus HbA1c ≤ 7
HbA1c ≥ 7,5
Stroke patients with severe diabetes mellitus HbA1c ≥ 7,5
- Functional outcome six months after the cerebral ischemia [ Time Frame: six months ]Functional outcome for the National Institutes of Health Stroke scale, the Barthel Index and Modified Ranking Scala six months after the cerebral ischemia.
- Additional cerebral ischemia [ Time Frame: six months ]Additional cerebral ischemia six months after the first cerebral ischemia
- Mortality [ Time Frame: sixt months ]Mortality in the first 6 months after the primary cerebral ischemia
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01172977
|Bielefeld, Germany, 33167|
|Principal Investigator:||Cristian Barzu, MD||Evangelisches Krankenhaus Bielefeld, Germany|